spectrum of PE may vary from sudden life-threatening events to unsuspected radiologic findings on scheduled CT scans. 2 , 3 In several series of patients with acute symptomatic PE, cancer has been identified as a predictor for adverse outcomes. 4 , 5
Search Results
Carme Font, Alberto Carmona-Bayonas, Aranzazu Fernández-Martinez, Carmen Beato, Andrés Vargas, Pere Gascon, and Remedios Otero
Joyce Valerie Veld, Femke Julie Amelung, Wernard Aat Antoine Borstlap, Emo Eise van Halsema, Esther Catharina Josephina Consten, Peter Derk Siersema, Frank ter Borg, Edwin Silvester van der Zaag, Paul Fockens, Willem Adrianus Bemelman, Jeanin Elise van Hooft, Pieter Job Tanis, and for the Dutch Snapshot Research Group
-term outcomes with additional procedural and long-term surgical and oncologic data through chart review using a web-based tool meeting Dutch privacy regulations by Medical Research Data Management. All 77 Dutch hospitals that register patients in the DCRA were
Emma B. Holliday, Arjun Peddireddy, and Van K. Morris
States. 3 Updated therapeutic approaches for patients with nonmetastatic and metastatic SCCA alike are needed to improve survival outcomes. Concurrent chemoradiation has remained the steadfast treatment for locoregional SCCA for the past half
Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Yang Li, Qing-Nan Tang, Xue-Song Sun, Yu-Jing Liang, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, and Hai-Qiang Mai
classifications have markedly different survival outcomes. Infection with Epstein-Barr virus (EBV) is strongly linked to NPC. 13 , 14 Previous studies have shown that patients with high levels of pretreatment plasma EBV DNA have higher rates of distant relapse
Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel
their cancer. Figure 1. Patients’ perceptions of their treatment goal and of their oncologist’s goal. Association Between Patients’ Perceptions of Treatment Goals and Patient-Reported Outcomes Figures 2 and 3 depict the rates of clinically significant
Linda Watson, Siwei Qi, Claire Link, Andrea DeIure, Arfan Afzal, and Lisa Barbera
associated severity directly impact the care they require, and patients with multiple and/or severe symptoms may need more support or use additional services. A study conducted in Ontario, Canada, used patient-reported outcomes (PROs) data to examine symptoms
Aruni Ghose, John Hayes, Nicolas Omorphos, Nikhil Vasdev, and Sharma Anand
revolutionised the treatment landscape. There exists a dearth of literature of real-world data on clinical trials focussing on immunotherapy treatment outcomes. Methods : Our study population included mUC patients treated at two large North West London Cancer
Michael Grimm, Kai Johnson, Patrick Schnell, Ashley Pariser, Margaret Gatti-Mays, Jeffrey VanDeusen, Nicole Williams, Daniel Stover, Sagar Sardesai, Robert Wesolowski, Preeti Sudheendra, Bhuvaneswari Ramaswamy, Ko Un Park, Sachin R Jhawar, Amy Kerger, and Mathew A Cherian
characteristics, treatment regimens, and survival outcomes between non-metastatic IBC patients and comprehensively matched patients with stage III invasive non-IBC based on age, stage, and biomarker status. Results : A total of 165 patients (84 IBC, 81 non
Zhihui Gao, Shen Sheng, Liu Han, Ni Xiaoling, Suo Tao, Wang Yueqi, and Houbao Liu
Background and aim: Indications of preoperative biliary drainage (PBD) for malignant obstructive jaundice are still controversial. The present study aims to assess the impact of preoperative biliary drainage on postoperative outcome, to define the
Henry Soo-Min Park
Over the course of the past quarter century, an increasing number of observational studies have been published investigating how surgeon and hospital experience can influence the outcomes of patients undergoing complex surgeries. Early studies
